Age and sex influence cystatin C in adolescents with and without type 1 diabetes - PubMed (original) (raw)
. 2011 Nov;34(11):2360-2.
doi: 10.2337/dc11-0829. Epub 2011 Sep 16.
Affiliations
- PMID: 21926294
- PMCID: PMC3198267
- DOI: 10.2337/dc11-0829
Age and sex influence cystatin C in adolescents with and without type 1 diabetes
David M Maahs et al. Diabetes Care. 2011 Nov.
Abstract
Objective: To compare serum cystatin C levels, a novel biomarker of renal function, in adolescents with and without type 1 diabetes and to determine what factors affect cystatin C levels.
Research design and methods: Cystatin C was measured in youth 12-19 years of age with (n = 259, diabetes duration 9 ± 3 years, HbA(1c) 8.9 ± 1.6%) and without diabetes (n = 78). Data were compared by diabetes status, and linear regression was used to determine factors affecting cystatin C.
Results: Cystatin C (0.698 ± 0.083 vs. 0.688 ± 0.127 mg/L, P = 0.40) was similar by diabetes status. In multiple linear regression, cystatin C was associated with age and serum creatinine in nondiabetic subjects and sex, age, and serum creatinine in subjects with diabetes (P < 0.05).
Conclusions: These data suggest sex differences and age-related changes in cystatin C in adolescents with type 1 diabetes. An understanding of these changes is needed to determine the potential role of cystatin C as a marker of renal function in this population.
Similar articles
- Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects.
Buysschaert M, Joudi I, Wallemacq P, Hermans MP. Buysschaert M, et al. Diabetes Metab. 2003 Sep;29(4 Pt 1):377-83. doi: 10.1016/s1262-3636(07)70048-4. Diabetes Metab. 2003. PMID: 14526265 - Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes).
Domingueti CP, Fóscolo RB, Dusse LMS, Reis JS, Carvalho MDG, Gomes KB, Fernandes AP. Domingueti CP, et al. Arch Endocrinol Metab. 2018 Feb;62(1):27-33. doi: 10.20945/2359-3997000000003. Arch Endocrinol Metab. 2018. PMID: 29694626 Free PMC article. - Cystatin C as a biomarker for estimating glomerular filtration rate.
Ferguson TW, Komenda P, Tangri N. Ferguson TW, et al. Curr Opin Nephrol Hypertens. 2015 May;24(3):295-300. doi: 10.1097/MNH.0000000000000115. Curr Opin Nephrol Hypertens. 2015. PMID: 26066476 Review. - Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations.
Weinert LS, Camargo EG, Soares AA, Silveiro SP. Weinert LS, et al. Clin Chem Lab Med. 2011 Nov;49(11):1761-71. doi: 10.1515/CCLM.2011.670. Epub 2011 Jul 14. Clin Chem Lab Med. 2011. PMID: 21756163 Review.
Cited by
- Association Between CST3 Gene Polymorphisms and Large-Artery Atherosclerotic Stroke.
Ding Y, Xu Z, Pan Y, Meng X, Xiang X, Li H, Liu L, Wang Y. Ding Y, et al. Front Neurol. 2021 Oct 13;12:738148. doi: 10.3389/fneur.2021.738148. eCollection 2021. Front Neurol. 2021. PMID: 34721268 Free PMC article. - Cystatin C, renal resistance index, and kidney injury molecule-1 are potential early predictors of diabetic kidney disease in children with type 1 diabetes.
Trutin I, Bajic Z, Turudic D, Cvitkovic-Roic A, Milosevic D. Trutin I, et al. Front Pediatr. 2022 Jul 29;10:962048. doi: 10.3389/fped.2022.962048. eCollection 2022. Front Pediatr. 2022. PMID: 35967553 Free PMC article. - Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients.
Stankute I, Radzeviciene L, Monstaviciene A, Dobrovolskiene R, Danyte E, Verkauskiene R. Stankute I, et al. Medicina (Kaunas). 2022 Feb 1;58(2):218. doi: 10.3390/medicina58020218. Medicina (Kaunas). 2022. PMID: 35208542 Free PMC article. - Early diabetic nephropathy in type 1 diabetes: new insights.
Bjornstad P, Cherney D, Maahs DM. Bjornstad P, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):279-86. doi: 10.1097/MED.0000000000000074. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24983394 Free PMC article. Review. - Serum cystatin C in youth with diabetes: The SEARCH for diabetes in youth study.
Kanakatti Shankar R, Dolan LM, Isom S, Saydah S, Maahs DM, Dabelea D, Reynolds K, Hirsch IB, Rodriguez BL, Mayer-Davis EJ, Marcovina S, D'Agostino R Jr, Mauer M, Mottl AK. Kanakatti Shankar R, et al. Diabetes Res Clin Pract. 2017 Aug;130:258-265. doi: 10.1016/j.diabres.2017.06.010. Epub 2017 Jun 12. Diabetes Res Clin Pract. 2017. PMID: 28666182 Free PMC article.
References
- Maahs DM, Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitus: progress made, more to be done. J Clin Endocrinol Metab 2006;91:3757–3759 - PubMed
- Maahs DM, Ogden LG, Kretowski A, et al. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes. Diabetes 2007;56:2774–2779 - PubMed
- Shlipak MG, Sarnak MJ, Katz R, et al. . Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049–2060 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 DK088833/DK/NIDDK NIH HHS/United States
- DK088833-01/DK/NIDDK NIH HHS/United States
- K23 DK075360/DK/NIDDK NIH HHS/United States
- DK075360/DK/NIDDK NIH HHS/United States
- UL1-RR-025780/RR/NCRR NIH HHS/United States
- R01 HL113029/HL/NHLBI NIH HHS/United States
- UL1 RR025780/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous